Summary
The deaminated monoamine metabolites 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG), 3,4-di-hydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were determined electrochemically following organic solvent extraction and reverse-phase, high performance, liquid chromatography in four regions of the mouse brain. In the noradrenaline (NA)-predominant regions (hemispheres, brain stem), the ratio of the concentrations of DOPAC plus HVA to NA plus dopamine (DA) was approximately the same as in the DA-predominant regions (corpus striatum, limbic system). Yohimbine and reserpine elevated the concentrations of DOPAC and HVA both in the NA-and the DA-predominant regions. The effect of yohimbine was somewhat enhanced by the α1-receptor blocking agent prazosin in the NA-predominant regions. The concentration of MOPEG was increased by yohimbine and decreased by reserpine.
The concentrations of DOPAC and HVA were lowered by clonidine, but not by apomorphine in the NA-predominant regions of reserpine-treated mice. In, the DA-predominant regions, apomorphine, but not clonidine, reduced the concentrations of DOPAC and HVA. The effects of clonidine and apomorphine were reversed by yohimbine and haloperidol, respectively.
The results indicate that the concentrations of the acid DA metabolites DOPAC and HVA in the NA-predominant regions reflect the rate of synthesis of DA in the NA neurons.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén N-E, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39:275–282
Andén N-E, Roos B-E, Werdinius B (1963) On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. Life Sci 7:448–458
Andén N-E, Grabowska M, Strömbom U (1976) Different alphaadrenoreceptors in the central nervous system mediating, biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch Pharmacol 292:43–52
Andén N-E, Gomes C, Persson B, Trolin G (1978) R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure. Naunyn-Schmiedeberg's Arch Pharmacol 302:299–306
Andén N-E, Golembiowska-Nikitin K, Thornström U (1982a) Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn-Schmiedeberg's Arch Pharmacol 321:100–104
Andén N-E, Pauksens K, Svensson K (1982b) Selective blockade of brain α2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine. J Neural Transm 55:111–120
Braestrup C, Nielsen M (1976) Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs. J Pharmacol Exp Ther 198:596–608
Carlsson A (1980) Psychopharmacology: basic aspects. In: Kisker KP, Meyer J-E, Müller C, Strömgren E (eds), Psychiatrie der Gegenwart, I, 2. Springer, Berlin Heidelberg New York, pp 198–242
Ceasar PM, Hague P, Sharman DF, Werdinius B (1974) Studies on the metabolism of catecholamines in the central nervous system of the mouse. Br J Pharmacol 51:187–195
Felice LJ, Felice JD, Kissinger PT (1978), Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 31:1461–1465
Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362
Persson T, Waldeck B (1970) Further studies on possible interaction between dopamine and noradrenaline containing neurons in the brain. Eur J Pharmacol 11:315–320
Rosengren E (1960) On the role of monoamine oxidase for the inactivation of dopamine in the brain. Acta Physiol Scand 49:370–375
Rutledge CO, Weiner N (1967) The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart. J Pharmacol Exp Ther 157:290–302
Scatton B, Zivkovic B, Dedek J (1980) Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther 215:494–499
Sharman DF (1963) A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Br J Pharmacol 20:204–213
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Warsh JJ, Godse DD, Cheung SW, Li PP (1981a) Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography. J Neurochem 36:893–901
Warsh JJ, Li PP, Godse DD, Cheung S (1981b) Brain noradrenergic neuronal activity affects 3,4-dihydroxyphenylethyleneglycol (DHPG) levels. Life Sci 29:1303–1307
Westerink BHC, Korf J (1976) Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur J Pharmacol 38:281–291
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, NE., Grabowska-Andén, M. Formation of deaminated metabolites of dopamine in noradrenaline neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 324, 1–6 (1983). https://doi.org/10.1007/BF00647830
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00647830